Our data contrasts somewhat with a recently published study by Li et al., which showed that the immunocompetent allograft HNSCC mouse model does not demonstrate the difference between WT and NSD1-knockout tumor growth; the authors explain this effect by the ability of NSD1 to affect the tumor-immune microenvironment [19]. The gene discussed is NSD1; the disease is head and neck squamous cell carcinoma.